-
Symbol
-
SAGE
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Latest Disclosed Ownership
-
0 shares
-
Security Ownership
-
0%
Biogen Inc. ownership in Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
2025-07-30 - Biogen Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE).
This represents 0% percent ownership of the company.
In their previous filing dated 2025-07-21, BIOGEN INC. had reported owning 6.24M shares, indicating a decrease of -100% percent.